Recent Finacing
Recent Raise
EQRx develops patent-protected oncology and inflammatory therapies via a market-based, efficient development model, advancing late-stage PD-L1, EGFR, PD-1, CDK4/6 candidates and partnering with payers and health systems to streamline access.
